L.L.J.K. Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 12-12-2024
- Paid Up Capital ₹ 1.48 M
as on 12-12-2024
- Company Age 39 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.70 Cr
as on 12-12-2024
- Revenue 35.45%
(FY 2022)
- Profit 50.09%
(FY 2022)
- Ebitda 18.04%
(FY 2022)
- Net Worth 10.95%
(FY 2022)
- Total Assets 17.20%
(FY 2022)
About L.L.J.K. Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.48 M.
The company currently has active open charges totaling ₹2.70 Cr.
Sarthak Rastogi, Sandhya Rastogi, and Deepak Rastogi serve as directors at the Company.
- CIN/LLPIN
U24111UP1985PTC007493
- Company No.
007493
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Oct 1985
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- LocationUttar Pradesh, Uttar Pradesh
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at L.L.J.K. Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Rastogi  | Managing Director | 28-Oct-1985 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sarthak Rastogi | Director | 29-Sep-2012 | Current |
| Sandhya Rastogi | Director | 19-Jul-1991 | Current |
Financial Performance of L.L.J.K. Pharmaceuticals.
L.L.J.K. Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 35.45% increase. The company also saw a substantial improvement in profitability, with a 50.09% increase in profit. The company's net worth Soared by an impressive increase of 10.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of L.L.J.K. Pharmaceuticals?
In 2021, L.L.J.K. Pharmaceuticals had a promoter holding of 42.59% and a public holding of 57.41%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hkd Warehousing Private LimitedActive 4 years 5 monthsSarthak Rastogi and Deepak Rastogi are mutual person
- Lljk Realtor And Farms Private LimitedActive 8 years 3 months
Sarthak Rastogi and Sandhya Rastogi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 08 Oct 2021 | ₹2.70 Cr | Open |
How Many Employees Work at L.L.J.K. Pharmaceuticals?
L.L.J.K. Pharmaceuticals has a workforce of 11 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of L.L.J.K. Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped L.L.J.K. Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
